Air cargo sees flurry of new routes between Europe and Asia
So far this year, four new airfreight services between Europe and Asia have been announced. Today, ...
Despite heavy marketing by some carriers and forwarders, standards in pharmaceutical logistics are not always as good as are billed, and should be further standardised, according to one pharma shipper.
Yulia Celetaria, head of logistics for Early Health Group, should know: she was global pharma director for Volga-Dnepr Group and AirBridgeCargo before making the rare move to become a shipper.
“There is often zero understanding among some shippers about the airline industry,” she told The Loadstar on the sidelines of the ACE ...
Maersk u-turn as port congestion increases across Northern Europe
Apple logistics chief Gal Dayan quits to join forwarding group
Maersk Air Cargo sees volumes fall as it aims for 'margin in favour of revenue'
Airlines slash freighter capacity post-de minimis, but 'the worst is yet to come'
Houthis tell Trump they will end attacks on Red Sea shipping
Transpac rates hold firm as capacity is diverted to Asia-Europe lanes
MSC revamps east-west network as alliance strategies on blanking vary
India-Pakistan 'tit-for-tat' cargo ban sparks sudden supply chain shocks
Comment on this article
Alan Kennedy
December 07, 2023 at 4:59 pmThis article contains some interesting and widely-held viewpoints. It is issues like these that have recently led to the industry coming together to take a collaborative approach to pharma Good Distribution Practice and regulatory compliance.
The non-profit GDP-UCI (Universal Compliance Initiative) has the goals of introducing new concepts for achieving, demonstrating and recording GDP compliance; of introducing the means for meaningful GDP measurement for comparison, benchmarking and continuous improvement purposes; and of creating abmore harmonised GDP training environment.
It is achieving these goals through the involvement and alignment of all the supply chain parties and disciplines that are involved in, or affected by, the GDP regulations and guidelines and, it is this collaborative approach that distinguishes it from other industry bodies that are active in this space.
GDP-UCI is a democratically-governed social enterprise that is neutral, fully independent and open to all organisations that are active in the field of pharmaceutical distribution.